AI assistant
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Apr 26, 2024
35599_dirs_2024-04-26_82ca2fd0-0ca5-466c-b75f-e3916bce1307.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-04-17
Reporting Person: Haigh Adrian (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-17 | Common Shares | M | 22222 | $2.31 | Acquired | 22222 | Direct |
| 2024-04-18 | Common Shares | M | 22222 | $2.31 | Acquired | 44444 | Direct |
Footnotes
F1: On April 18, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 17, 2024, and an additional 22,222 common shares on April 18, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M".
F2: On April 18, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 17, 2024, and an additional 22,222 common shares on April 18, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M".